Several brokerages have updated their recommendations and price targets on shares of Morgan Stanley (NYSE: MS) in the last few weeks:

  • 9/25/2017 – Morgan Stanley had its “sell” rating reaffirmed by analysts at Compass Point. They now have a $38.00 price target on the stock, up previously from $34.00.
  • 9/21/2017 – Morgan Stanley had its “hold” rating reaffirmed by analysts at Berenberg Bank. They now have a $40.00 price target on the stock.
  • 9/15/2017 – Morgan Stanley was upgraded by analysts at HSBC Holdings plc from a “hold” rating to a “buy” rating. They now have a $53.00 price target on the stock.
  • 9/15/2017 – Morgan Stanley was given a new $53.00 price target on by analysts at J P Morgan Chase & Co. They now have a “buy” rating on the stock.
  • 9/13/2017 – Morgan Stanley was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Morgan Stanley's shares have significantly outperformed the industry, over the last six months. The performance was supported by the company’s impressive earnings surprise history. It surpassed the Zacks Consensus Estimate for earnings in all the trailing four quarters. The company’s efforts to offload its non-core assets to lower balance sheet risk and cost saving initiatives (Project Stremline) will likely lead to improvement in profitability. However, continued fall in corporate loan balances remains a near-term concern. This is significantly hurting the company's interest income growth.”
  • 9/11/2017 – Morgan Stanley was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $49.00 price target on the stock. According to Zacks, “Morgan Stanley's shares have significantly outperformed the industry, over the last six months. The performance was supported by the company’s impressive earnings surprise history. It surpassed the Zacks Consensus Estimate for earnings in all the trailing four quarters. The company’s efforts to offload its non-core assets to lower balance sheet risk and cost saving initiatives (Project Stremline) will likely lead to improvement in profitability. These initiatives, along with enhanced capital deployment should boost investors’ confidence in the stock.  However, continued fall in corporate loan balances leading to decline in interest income remains a near-term concern for the company.”
  • 9/1/2017 – Morgan Stanley was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating.
  • 8/11/2017 – Morgan Stanley was given a new $54.00 price target on by analysts at HSBC Holdings plc. They now have a “hold” rating on the stock.
  • 8/9/2017 – Morgan Stanley is now covered by analysts at Wells Fargo & Company. They set a “market perform” rating and a $48.00 price target on the stock.

Shares of Morgan Stanley (NYSE MS) traded up 0.74% during midday trading on Tuesday, hitting $49.28. The company’s stock had a trading volume of 6,294,308 shares. Morgan Stanley has a 1-year low of $30.96 and a 1-year high of $49.35. The company has a 50-day moving average price of $46.33 and a 200 day moving average price of $44.64. The company has a market cap of $90.51 billion, a P/E ratio of 14.12 and a beta of 1.61. Morgan Stanley also was the target of unusually large options trading activity on Monday. Investors acquired 6,765 call options on the company. This is an increase of approximately 381% compared to the average daily volume of 1,407 call options.

Morgan Stanley (NYSE:MS) last released its earnings results on Wednesday, July 19th. The financial services provider reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.76 by $0.11. The business had revenue of $9.50 billion for the quarter, compared to analyst estimates of $9.05 billion. Morgan Stanley had a net margin of 16.77% and a return on equity of 9.83%. Morgan Stanley’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.75 earnings per share. On average, equities research analysts predict that Morgan Stanley will post $3.48 EPS for the current year.

In other Morgan Stanley news, Chairman James P. Gorman sold 212,366 shares of the stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $47.26, for a total transaction of $10,036,417.16. Following the transaction, the chairman now directly owns 1,602,609 shares in the company, valued at approximately $75,739,301.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jonathan Pruzan sold 25,767 shares of the stock in a transaction that occurred on Thursday, July 20th. The stock was sold at an average price of $46.68, for a total value of $1,202,803.56. Following the transaction, the chief financial officer now owns 196,708 shares in the company, valued at $9,182,329.44. The disclosure for this sale can be found here. Company insiders own 0.24% of the company’s stock.

Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with Analyst Ratings Network's FREE daily email newsletter.